Allergy & Clinical Immunology News
- GRAPPA 2024 Psoriasis: Tissue Resident Memory T Cells Play Complex Role
- Cendakimab Clears Skin in Adults With Atopic Dermatitis
- Beauty Bloggers Dominate TikTok's Sun Protection Content
- More Illnesses Linked to Counterfeit Botulinum Toxin
- SPD 2024 Response Rates With Vitiligo Rx Higher Among Adolescents
- SPD 2024 Kids With Obesity at Higher Risk for Skin Conditions
- New Tactic to Speed Long COVID Treatments to Patients
- Three AI Technologies Poised to Transform IBD Care
- Cytomegalovirus Shown to Cause Glioblastoma
- EMA Warns of Anaphylactic Reactions to MS Drug
- AD in Older Adults: Common, Unique, Challenging to Manage
- Alert FDA Approves Topical Eczema Rx for Ages 6 or Older
- Dupilumab Safe, Effective Over 5 Years in Moderate-Severe AD
- Spironolactone May Benefit Women With HS
- Sugar Tax Yields Sweet Health Benefits
- Review: Dupilumab Benefits Kids With AD and Alopecia Areata
- Olympic Mindset Tips Tailor-Made for Stressed-Out Physicians
- Dermatoporosis: Holistic, Creative Management Needed
- US, Mexican Border Restrictions Did Not Reduce HIV Infection
- Confronting Healthcare Disinformation on Social Media